EP2305255B1 - Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers - Google Patents

Aryl urea compounds in combination with other cytostatic or cytotoxic agents for treating human cancers Download PDF

Info

Publication number
EP2305255B1
EP2305255B1 EP10183659A EP10183659A EP2305255B1 EP 2305255 B1 EP2305255 B1 EP 2305255B1 EP 10183659 A EP10183659 A EP 10183659A EP 10183659 A EP10183659 A EP 10183659A EP 2305255 B1 EP2305255 B1 EP 2305255B1
Authority
EP
European Patent Office
Prior art keywords
administered
aryl urea
use
urea compound
fluorouracil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP10183659A
Other languages
German (de)
French (fr)
Other versions
EP2305255A1 (en
Inventor
Christopher A. Carter
Neil Gibson
Barbara Hibner
Rachel W. Humphrey
Pamela Trail
Patrick Vincent
Yifan Zhai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Healthcare LLC
Original Assignee
Bayer Healthcare LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US33460901P priority Critical
Application filed by Bayer Healthcare LLC filed Critical Bayer Healthcare LLC
Priority to EP02786842.1A priority patent/EP1450799B2/en
Priority to EP06023696.5A priority patent/EP1769795B1/en
Publication of EP2305255A1 publication Critical patent/EP2305255A1/en
Application granted granted Critical
Publication of EP2305255B1 publication Critical patent/EP2305255B1/en
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links